Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Keng, MJ"'
Publikováno v:
Diabetes, Obesity and Metabolism. 24:530-538
Aim People with diabetes are at elevated risk of adverse events due to the disease and treatments. We estimate the decrements in health-related quality of life (QoL) associated with a range of adverse events. This will inform assessments of the effec
Autor:
Keng, MJ
Decision-analytic modelling is used to synthesise clinical and economic data to evaluate health outcomes and costs of novel healthcare interventions. Diabetes is associated with disabling and costly complications which develop over time, and such mod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9422d9a80268110204a9128ec5056d40
Objectives: The UKPDS Outcomes Model developed using 30-year (1977-2007) data from the UKPDS is widely used for health outcomes’ projections and economic evaluations of therapies for patients with type 2 diabetes (T2D). However, its reliability for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::319dbd6168b0d833f13b3eea9b876527
https://ora.ox.ac.uk/objects/uuid:1a27d0da-8bda-4b4a-bb27-a193b574c07a
https://ora.ox.ac.uk/objects/uuid:1a27d0da-8bda-4b4a-bb27-a193b574c07a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
American Journal of Physical Medicine & Rehabilitation; May2006, Vol. 85 Issue 5, p415-423, 9p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Altunkaya J; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, England, UK. Electronic address: james.altunkaya@ndph.ox.ac.uk., Li X; Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands., Adler A; Diabetes Trial Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, England, UK., Feenstra T; Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Fridhammar A; The Swedish Institute for Health Economics, Lund, Sweden., Keng MJ; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, England, UK., Lamotte M; IQVIA, Zaventem, Belgium; Th(is)(2)Modeling, Asse, Belgium., McEwan P; Health Economics and Outcomes Research Ltd, Cardiff, Wales, UK., Nilsson A; IQVIA, Zaventem, Belgium., Palmer AJ; Menzies Institute for Medical Research, The University of Tasmania, Hobart, Tasmania, Australia., Quan J; School of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong., Smolen H; Medical Decision Modeling Inc, Indianapolis, IN, USA., Tran-Duy A; Centre for Health Policy, Melbourne School of Population and Global Health, the University of Melbourne, Melbourne, VIC, Australia; Australian Centre for Accelerating Diabetes Innovations (ACADI), Melbourne Medical School, University of Melbourne, Melbourne, VIC, Australia., Valentine W; Ossian Health Economics and Communications, Basel, Switzerland., Willis M; The Swedish Institute for Health Economics, Lund, Sweden., Leal J; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, England, UK., Clarke P; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, England, UK.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Oct; Vol. 27 (10), pp. 1338-1347. Date of Electronic Publication: 2024 Jul 08.
Autor:
Zhou J; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, OX3 7LF, UK. junwen.zhou@ndph.ox.ac.uk., Williams C; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, OX3 7LF, UK., Keng MJ; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, OX3 7LF, UK., Wu R; Health Economics and Policy Research Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK., Mihaylova B; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, OX3 7LF, UK.; Health Economics and Policy Research Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Publikováno v:
PharmacoEconomics [Pharmacoeconomics] 2024 Mar; Vol. 42 (3), pp. 261-273. Date of Electronic Publication: 2023 Nov 10.
Autor:
Lui JNM; Health Economics Research Centre, Nuffield Department of Population Health University of Oxford Oxford United Kingdom., Williams C; Health Economics Research Centre, Nuffield Department of Population Health University of Oxford Oxford United Kingdom., Keng MJ; Health Economics Research Centre, Nuffield Department of Population Health University of Oxford Oxford United Kingdom., Hopewell JC; Clinical Trial Service Unit and Epidemiological Studies Unit Nuffield Department of Population Health University of Oxford United Kingdom., Sammons E; Clinical Trial Service Unit and Epidemiological Studies Unit Nuffield Department of Population Health University of Oxford United Kingdom., Chen F; Clinical Trial Service Unit and Epidemiological Studies Unit Nuffield Department of Population Health University of Oxford United Kingdom., Gray A; Health Economics Research Centre, Nuffield Department of Population Health University of Oxford Oxford United Kingdom., Bowman L; Clinical Trial Service Unit and Epidemiological Studies Unit Nuffield Department of Population Health University of Oxford United Kingdom.; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health University of Oxford United Kingdom., Landray SMJ; Clinical Trial Service Unit and Epidemiological Studies Unit Nuffield Department of Population Health University of Oxford United Kingdom., Mihaylova B; Health Economics and Policy Research Unit, Wolfson Institute of Population Health Queen Mary University of London United Kingdom.
Publikováno v:
Journal of the American Heart Association [J Am Heart Assoc] 2023 Oct 03; Vol. 12 (19), pp. e030766. Date of Electronic Publication: 2023 Sep 26.
Autor:
Keng MJ; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; British Heart Foundation Centre of Research Excellence, Oxford, UK., Leal J; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Bowman L; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Armitage J; British Heart Foundation Centre of Research Excellence, Oxford, UK.; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Mihaylova B; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2022 Nov; Vol. 24 (11), pp. 2108-2117. Date of Electronic Publication: 2022 Jun 29.